AR067465A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT

Info

Publication number
AR067465A1
AR067465A1 ARP080102923A ARP080102923A AR067465A1 AR 067465 A1 AR067465 A1 AR 067465A1 AR P080102923 A ARP080102923 A AR P080102923A AR P080102923 A ARP080102923 A AR P080102923A AR 067465 A1 AR067465 A1 AR 067465A1
Authority
AR
Argentina
Prior art keywords
agent
benzisoxazolic
pharmaceutical composition
benzodiazepinic
combination
Prior art date
Application number
ARP080102923A
Other languages
Spanish (es)
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of AR067465A1 publication Critical patent/AR067465A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composicion farmacéutica compuesta por la combinacion sinérgica de un agente derivado benzisoxazolico como lo es el principio activo: Risperidona y un agente benzodiazepínico como lo es el principio activo: Clonazepam, los cuáles se encuentran formulados en una sola unidad de dosificacion para ser administrada por vía oral en forma de cápsulas o tabletas, misma que está indicada para el control y tratamiento de enfermedades, tales como: trastornos psicoticos y patologías relacionadas.Pharmaceutical composition composed of the synergistic combination of a benzisoxazolic derivative agent such as the active substance: Risperidone and a benzodiazepineic agent such as the active substance: Clonazepam, which are formulated in a single dosage unit to be administered orally in the form of capsules or tablets, which is indicated for the control and treatment of diseases, such as: psychotic disorders and related pathologies.

ARP080102923A 2007-07-06 2008-07-07 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT AR067465A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MX2007008323A MX2007008323A (en) 2007-07-06 2007-07-06 Pharmaceutical composition comprising the combination of a benzisoxazolic derived agent and a benzodiazepinic agent.
PCT/MX2008/000084 WO2009008695A1 (en) 2007-07-06 2008-07-04 Pharmaceutical composition comprising the combination of risperidone (benzisoxazolic agent) and clonazepam (benzodiazepinic agent) and use thereof in psychotic disorders and related pathologies

Publications (1)

Publication Number Publication Date
AR067465A1 true AR067465A1 (en) 2009-10-14

Family

ID=40228771

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102923A AR067465A1 (en) 2007-07-06 2008-07-07 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT

Country Status (4)

Country Link
AR (1) AR067465A1 (en)
MX (1) MX2007008323A (en)
UY (1) UY31212A1 (en)
WO (1) WO2009008695A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10190625B2 (en) 2014-11-18 2019-01-29 Ntn Corporation Thrust roller bearing cage and method for manufacturing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05012317A (en) * 2003-05-16 2006-01-30 Pfizer Prod Inc Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines.

Also Published As

Publication number Publication date
UY31212A1 (en) 2009-01-05
WO2009008695A1 (en) 2009-01-15
MX2007008323A (en) 2009-02-18

Similar Documents

Publication Publication Date Title
MX2009003372A (en) Non-mucoadhesive film dosage forms.
UY35624A (en) USE OF HIGH DOSE PRIDOPIDINE TO TREAT HUNTINGTON'S DISEASE
ES2916649T1 (en) Compositions and uses for the treatment of multiple sclerosis
ECSP10010224A (en) LUTEINIZING HORMONE LIQUID FORMULATIONS (LH).
AR091351A1 (en) BROMOCRIPTINE FORMULATIONS, METHOD FOR IMPROVING GLUCEMIC CONTROL AND METHOD FOR MANUFACTURING
BR112014014795A2 (en) immediate release multi-unit pellet system
PE20040973A1 (en) COMPOSITIONS OF ANTI-HISTAMINES, DECONGESTIVES AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
ECSP099734A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
AR083095A1 (en) APREPITANT L-PROLINA AND PHARMACEUTICAL COMPOSITION CO-CRYSTAL
ECSP10010054A (en) PHARMACEUTICAL COMPOSITIONS UNDERSTANDING THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN INHIBITING AGENT OF XANTINO OXIDASA USEFUL FOR THE CONTROL AND TREATMENT OF THE DROP, GOTOUS ARTHRITIS AND RELATED DISEASES
AR067465A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT
DOP2010000265A (en) ORAL GALENIC FORMULATION INCLUDING KETOROLACO AND VITAMINS OF COMPLEX B, IN WHICH VITAMIN B6 IS FOUND AN EXTERNAL LAYER SEPARATED FROM THE REST OF ACTIVE PRINCIPLES
AR074246A1 (en) DERIVATIVES OF 1-AMINO-ALQUILCICLOHEXANO FOR THE TREATMENT OF SOIL DISORDERS
UY31230A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSION AGENT AND A BENZODIAZEPINIC AGENT, INDICATED FOR THE CONTROL AND TREATMENT OF CONVULSIVE DISORDERS AND EPILEPTIC SYNDROMES.
AR069538A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A REVERSIBLE INHIBITING AGENT OF CHOLINESTERASE ENZYME, INDICATED FOR THE CONTROL AND TREATMENT OF PSYCHOTIC DISORDERS AND DEMENCIES
PE20090316A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS
UY31248A1 (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF AN ANTIANDROGEN AGENT, A SYNTHETIC STERETIC STROGEN AGENT AND VITAMINAL AGENTS, USEFUL FOR THE CONTROL AND TREATMENT OF LATE ACNE IN WOMEN
UY31362A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING THE COMBINATION OF AN ANTIARTHRITIC AGENT AND AN INHIBITING AGENT OF INTERLEUCIN-1, USEFUL FOR THE CONTROL AND TREATMENT OF OSTEOARTROSIS AND RELATED DISEASES
AR071736A1 (en) PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF VARIOUS ANTISPASMODIC AGENTS AND AN NON-STEROID ANTI-INFLAMMATORY AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF RENAL COLICO AND INFLAMMATION
AR068382A1 (en) PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF A STEROID ANTI-INFLAMMATORY AND A RELATED MUSCULAR RELAXANT FOR THE CONROLLMENT AND TREATMENT OF MUSCLE SKELETTIC INFLAMMATORY DISEASES ACCOMPANYING MUSCLE CONTRACT
AR067466A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIDEPRESSIVE AGENT AND AN ANSIOLITIC AGENT FOR THE CONTROL OF DEPRESSIVE DISORDERS
PE20091200A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING A COMBINATION OF ACEMETACIN, METHOCARBAMOL AND DIACEREIN
AR076016A1 (en) DOMPERIDONE AT A LOW DAILY DOSE FOR USE IN THE TREATMENT OR PREVENTION OF AN ILLNESS ASSOCIATED WITH AN ALTERATION OF THE IMMUNE RESPONSE
CO6241103A2 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
AR084895A1 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PATHOLOGY INDUCED BY OXIDATIVE STRESS AND USE OF THE SAME

Legal Events

Date Code Title Description
FB Suspension of granting procedure